xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

620

International consensus statement on rhinosinusitis

Park MM silastic stents are well-tolerated and may be associated with decreased synechia

improved antrostomy patency rate

No synechia observed at any time point

Dragon-fly stents are well-tolerated and

highly efficient at

preventing synechia

–5- month rate of synechia Silastic in the MM in settingof floppy/deficient MT prevents lateral

synechia formation

No complications as a result of using this stent

Author Year LOE Study Design Study Groups Clinical Endpoint Conclusions Mantovani 2218 2014 4 Descriptive case series

Silicone OMU stent

–9- to 36- month presence of MTL or adhesions

–3- to 18- month symptoms, antrostomy size, adhesions

–3-, 6-, 12-, and 18- month presence of synechia

Salman 2215 1993 4 Descriptive case series –Silicone MM stent x 10-14 days –2 years (not specified endpoints)

patients with deficient MT x 2 weeks

–Unilateral silicone OMU stent x 10-14 days

polypropylene bi-winged

(dragon-fly) stents x 4 weeks – both MM and nasal valve stent

–MM silastic Park stents in all

–Contralateral OMU no stent

–25 patients (35 stents)

Lee 2214 2007 4 Case control –MM silastic x 10-14 days –MM no stent

Khwaja 2217 2011 4 Descriptive cases series

Shikani 2216 1994 4 Cohort, poor data reporting

TABLE XII-22 (Continued)